<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> is an acquired prothrombotic state where <z:mp ids='MP_0005048'>thrombosis</z:mp> and/or pregnancy loss is related to the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Cutaneous <z:mp ids='MP_0001651'>necrosis</z:mp> secondary to intravascular <z:mp ids='MP_0005048'>thrombosis</z:mp> of small dermal vessels is a recognized but rare association with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We report two patients with high circulating levels of anticardiolipin antibodies who developed widespread cutaneous <z:mp ids='MP_0001651'>necrosis</z:mp> as the first clinical manifestation of the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The exact mechanism by which <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> mediate <z:mp ids='MP_0005048'>thrombosis</z:mp> is uncertain; however, proposed mechanisms of activity include endothelial cell activation, altered endothelial production of prostacyclin, activation of platelets, and modulation of the protein C and S pathways </plain></SENT>
</text></document>